Deep Track Capital, LP Esperion Therapeutics, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $8.33 Million - $13.9 Million	-1,636,587 Reduced 29.04%	4,000,000 $24.9 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $1.98 Million - $2.95 Million	-363,413 Reduced 6.06%	5,636,587 $37.8 Million
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $1.2 Million - $1.99 Million	358,332 Added 6.35%	6,000,000 $27.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $27.1 Million - $67.2 Million	5,641,668 New	5,641,668 $28.2 Million

211

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.